Drug Approvals
Pfizer Stock Surges as Its Oral Weight-Loss Drug Challenges Ozempic
Here's what traders need to know.
Lilly Has a Hot Obesity Drug: Here's How to Trade the Stock
On top of all the other best-selling drugs in the firm's stable, Mounjaro has game-changer type potential.
Take a Look Under the Microscope at These Two Biopharma Stocks
I've noticed that biotech has been one area of strength lately.
Novavax Rallies and More Gains May Lie Ahead
Here's where aggressive traders could go long.
Eli Lilly Stock Has Soared $100 Since March: Ride the Wave After Drug Results?
Amid positive news for Alzheimer's drug, donanemab, here's where the stock may be headed next.
Will Eli Lilly's Rally Continue? Here's How to Trade the Stock
Q1 revenue growth was driven by several drugs.
Regeneron Set to Reach New Heights: $1,000 in Sight?
Here's how traders can play it.
Is Eli Lilly Ready to Resume Its Uptrend?
Traders should operate from the long side.
Here's Why Inozyme Pharma Has My Attention
Let's check the charts and indicators.
Why Weakness in Sarepta Therapeutics Is Likely to Continue
The trading days between the gaps look like an island surrounded by water.